SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals Initiates ...
4-traders
"DLBCL consolidation therapy is a setting in which rituximab maintenance has failed to show benefit in two randomized clinical trials, whereas multiple Phase 2 studies have shown encouraging results for ZEVALIN consolidation in this setting. We feel ...
Spectrum Pharmaceuticals Initiates Phase 3 Study of ZEVALINEquities.com
Spectrum Pharma (SPPI) Commences Phase 3 ZERT of ZEVALINStreetInsider.com (subscription)

all 12 news articles »